Phase 2 study of Dolorac nasal solution for the prophylaxis of chronic migraine (CM) - MPR
Links shared publicly online about this topic.
- 706total visits
Phase 2 study of Dolorac nasal solution for the prophylaxis of chronic migraine (CM) - MPR
empr.com —
Winston Pharmaceuticals announced the results of its Phase 2 study of Dolorac (doxepin 0.4% nasal solution) for prophylaxis of chronic migraine (CM).
View full resource at empr.com
Tags: Migraine, Headache, Vascular Headache, Nose, Pharma, Phase 2 Clinical Trial, News
Most Recently Shared on November 23, 2010 at 7:17 pm By:
MPR News: Phase 2 study of Dolorac nasal solution for the prophylaxis of chronic migraine (CM): Winston Pharmace... http://bit.ly/i0n4g1
Advertisement
